Biocon Q3 net profit tanks 46%
The company said the fall in profit was due to increase in interest and depreciation costs related to Malaysia operations and lower licensing income
Biotechnology major Biocon today announced a 46.35% fall in its consolidated net profit at Rs 91.9 crore for the third quarter ended December 31, 2017, against Rs 171.3 crore in the same quarter a year ago.
The company said the fall in profit was due to increase in interest and depreciation costs related to Malaysia operations and lower licensing income.
Consolidated revenue from operations of the company stood at Rs 1,057.9 crore for the quarter under consideration as against Rs 1,044.4 crore for the same period year ago.
"This has been a significant quarter for Biocon as we crossed a major milestone of obtaining USFDA approval for biosimilar Trastuzumab partnered with Mylan," Biocon Chairperson and MD Kiran Mazumdar-Shaw said.
Small molecules business, which reported revenue of Rs 369 crore, continues to face headwinds arising from pricing pressures and channel consolidation in the US impacting the statins business, it added.
"However, continued demand for our immunosuppressants offset some of the pressure," Biocon said.
"The bottom line for the quarter was impacted by a 42% increase in interest and depreciation costs to Rs 112 crore largely attributable to Malaysia," Biocon said.
Small molecules business, which reported revenue of Rs 369 crore, continues to face headwinds arising from pricing pressures and channel consolidation in the US impacting the statins business, it added.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Retirement Planning: SIP+SWP combination; Rs 15,000 monthly SIP for 25 years and then Rs 1,52,000 monthly income for 30 years
Retirement Calculator: 40 years of age, Rs 50,000 monthly expenses; what should be retirement corpus and monthly investment
SBI 444-day FD vs Union Bank of India 333-day FD: Know maturity amount on Rs 4 lakh and Rs 8 lakh investments for general and senior citizens
EPF vs SIP vs PPF Calculator: Rs 12,000 monthly investment for 30 years; which can create highest retirement corpus
Home loan EMI vs Mutual Fund SIP Calculator: Rs 70 lakh home loan EMI for 20 years or SIP equal to EMI for 10 years; which can be easier route to buy home; know maths
07:50 PM IST